Rare diseases, defined in the U.S. as conditions affecting fewer than 200,000 people, can take years, if not decades, to ...
The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), ...
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its launch on Aura, Epic’s specialty diagnostics ...
Exome, genome, and panel NGS tests have different genomic coverage characteristics. NGS gene panel tests cover a set of genes defined by the clinical diagnostic laboratory. The panel will typically ...
Agilent Technologies introduced SureSelect Human All-Exon V5 and V5 + UTRs for next-generation sequencing. The new all-exon solutions incorporate the latest advances from Agilent Genomics, the ...
Scientists at the Baylor College of Medicine and collaborating institutions used complementary approaches that integrate exome sequencing and evolutionary action machine learning to identify protein ...
Survival outcomes of patients with de novo stage metastatic head and neck cancer: A single center experience. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
7d
Baylor Genetics Connects with Genetic Counselors to Advance Answers in Rare and Undiagnosed Disease
HOUSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it ...
The optimising EXome PREnatal Sequencing Services (EXPRESS) policy report outlines actions to strengthen clinical implementation of, and further research on, prenatal exome sequencing services in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results